Decreased renal function does not change the single-dose pharmacokinetics for metronidazole. Subjects with ESRD had no significant change in pharmacokinetics, but had higher Cmax of metabolites ...
Decreased renal function does not change the single-dose pharmacokinetics for metronidazole. Subjects with ESRD had no significant change in pharmacokinetics, but had higher Cmax of metabolites ...
Approximately 5% to 10% of women with IAI will develop bacteremia. [10] Other maternal complications include labor abnormalities, increased need for oxytocin, and increased risk of cesarean birth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results